Roger Fassler

Title: Innovations by Roger Fassler in Cardiovascular Treatments

Introduction

Roger Fassler is an accomplished inventor based in Langwiesen, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new crystalline forms of perindopril erbumine. With a total of 2 patents, his work focuses on improving therapeutic options for cardiovascular diseases.

Latest Patents

Fassler's latest patents disclose two new crystalline forms, δ and ε, of perindopril erbumine. These forms are suitable as therapeutic active substances for medicaments aimed at treating cardiovascular diseases, especially high blood pressure and heart failure. The ε crystalline form is obtained through a specific crystallization process involving MTBE and controlled temperature conditions. This innovative approach enhances the efficacy of the medication, providing better treatment options for patients.

Career Highlights

Roger Fassler has been instrumental in advancing pharmaceutical research through his innovative work. His patents reflect a deep understanding of chemical processes and their applications in medicine. He is associated with Les Laboratoires Servier, a company known for its commitment to developing effective healthcare solutions.

Collaborations

Fassler has collaborated with notable colleagues, including Christoph Strassler and Vit Lellek. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical innovation.

Conclusion

Roger Fassler's contributions to the development of new crystalline forms of perindopril erbumine highlight his dedication to improving cardiovascular treatments. His innovative work continues to impact the pharmaceutical industry positively.